Fairvalue-Calculator Fairvalue-Calculator

Atria Oyj (ATRAV) Fair Value & Analysis

Consumer Defensive · FI · Market cap €420M

Price€15.24
Fair Value€35.54
Upside+133.2%
Quality92/100
Evidence: High Range €21.63 – €53.16

Analysis

Atria Oyj (ATRAV) currently trades at €15.24, while our model-based Fair Value estimate is €35.54 — implying the stock looks roughly 133.2% undervalued today. We read business quality at 92/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Atria Oyj, together with its subsidiaries, manufactures and markets food products in Finland, Sweden, Denmark, and Estonia. The company offers fresh and consumer-packed meat; poultry products; cooking products, such as cooking sausages; sandwich toppings; convenience food; animal feed; cold cuts and spreads; vegetable and delicatessen products; ready meals; and plant-based products. It sells its products under the Atria, Jyvä Broiler, Forssan, Wilhelm, Sibylla, Ridderheims, Lönnenberga, Lithells, Arboga, Gooh!, 3-Stjernet, Maks & Moorits, Wõro, Aalbaek, and VK brands. The company serves consumers, retail trade, the food service sector, and the food industry. It exports its products to 25 countries. The company was formerly known as Atria Group Oyj and changed its name to Atria Oyj in May 2008. Atria Oyj was founded in 1903 and is headquartered in Seinäjoki, Finland.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.